Overview
Dr. Gregory is the Margaret Harris and David Silverman Distinguished Professor and Director of the Brain Tumor Omics Program in the Duke Department of Neurosurgery, the Vice Chair of Research in the Department of Neurology, and Director of the Molecular Genomics Core at the Duke Molecular Physiology Institute.
As a neurogenomicist, Dr. Gregory applies the experience gained from leading the sequencing of chromosome 1 for the Human Genome Project to elucidating the mechanisms underlying multi-factorial diseases using genetic, genomic, and epigenetic approaches. Dr. Gregory’s primary areas of research involve understanding the molecular processes associated with disease development and progression in brain tumors and Alzheimer’s disease, drug induced white matter injury repair in multiple sclerosis, and the characterization of lesion microenvironmental changes in MS.
He is broadly regarded across Duke as a leader in the development of novel single cell and spatial molecular technologies towards understanding the pathogenic mechanisms of disease development. Dr. Gregory is also the Section Chair of Genomics and Epigenetics at the DMPI and Director of the Duke Center of Autoimmunity and MS in the Department of Neurology.
Current Duke Appointments & Affiliations
Recent Scholarly Works
Tumor-infiltrating plasma cell profiling after PD-1 blockade reveals tumor-specific antibodies.
Journal article Cancer Cell · September 14, 2026 The role of tumor-infiltrating B cells (TIL-Bs) in shaping anti-tumor responses in the context of immune checkpoint blockade remains incompletely understood. Here, we interrogate the humoral response in resected lung tumors from patients with non-small cel ... Full text Link to item CiteHost eicosanoid signals define a granuloma fibroblast population that coordinates mycobacterial containment.
Journal article Cell Host Microbe · September 9, 2026 Genetic variation at the leukotriene A4 hydrolase (LTA4H) locus is associated with tuberculosis (TB) severity and outcome. Here, we define a unique population of peripheral fibroblasts at the mycobacterial granuloma, the central immune structure in TB, who ... Full text Link to item CiteProtective and Detrimental Roles of NLRP6 in Infection and Cancer
Journal article Receptors Switzerland · September 1, 2026 NLRP6 is a member of the NOD-like receptor family that was initially characterized as an inflammasome-forming sensor in the intestine. However, accumulating evidence over the past decade has revealed that the functions of NLRP6 extend far beyond this canon ... Full text CiteRecent Grants
Innate immune memory for glioma immunotherapy
ResearchCo Investigator · Awarded by National Institutes of Health · 2026 - 2031ABL kinase signaling networks regulate Transcription-Replication Collisions in Small Cell Lung Cancer
ResearchCollaborating Investigator · Awarded by National Institutes of Health · 2026 - 2031Computational Biology and Bioinformatics Training Grant
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2026 - 2031View All Grants